Plain-English translation of NCT06725576 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is comparing two different ways to treat early-stage papillary thyroid cancer: microwave ablation (a newer technique that uses heat to destroy cancer cells under ultrasound guidance) and traditional thyroid surgery. Researchers want to understand how well each approach works and whether genetic information about your cancer can help decide which treatment is best for you.
Traditionally, surgery has been the standard treatment for thyroid cancer, but microwave ablation is a newer, less invasive option that may avoid some of surgery's side effects. This study exists to see whether the newer heat treatment can work just as well as surgery for patients with the earliest, lowest-risk forms of this cancer.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will choose either the microwave ablation treatment or surgery based on your preference and your doctor's recommendation. You will then undergo ultrasound imaging and genetic testing to confirm you are a good fit for the study. After your treatment, you will return for regular follow-up appointments with ultrasound scans to check how well the treatment worked and monitor for any side effects, with follow-up continuing through November 2024.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China